We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$3.26B
AUM Growth
+$218M
Cap. Flow
+$69.5M
Cap. Flow %
2.13%
Top 10 Hldgs %
26.89%
Holding
1,039
New
49
Increased
487
Reduced
330
Closed
41

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 15.72%
3 Healthcare 13.72%
4 Consumer Discretionary 12.72%
5 Communication Services 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASIX icon
526
AdvanSix
ASIX
$541M
$323K 0.01%
11,836
+3,608
+44% +$93.4K
VEA icon
527
Vanguard FTSE Developed Markets ETF
VEA
$229B
$318K 0.01%
+8,092
New +$310K
VSTO
528
DELISTED
Vista Outdoor Inc.
VSTO
$315K 0.01%
15,288
+12,264
+406% +$303K
LUX
529
DELISTED
Luxottica Group
LUX
$310K 0.01%
5,632
AGNC icon
530
AGNC Investment
AGNC
$12.4B
$309K 0.01%
15,510
+8,404
+118% +$162K
TTWO icon
531
Take-Two Interactive
TTWO
$45.4B
$309K 0.01%
5,208
+980
+23% +$54.7K
ING icon
532
ING
ING
$99.8B
$303K 0.01%
20,086
RGC
533
DELISTED
Regal Entertainment Group
RGC
$300K 0.01%
+13,288
New +$293K
EV
534
DELISTED
Eaton Vance Corp.
EV
$295K 0.01%
6,552
+1,344
+26% +$59.6K
COHR
535
DELISTED
Coherent Inc
COHR
$294K 0.01%
1,428
-204
-13% -$35.7K
CRL icon
536
Charles River Laboratories
CRL
$11.2B
$293K 0.01%
3,256
-132
-4% -$11.2K
DEI icon
537
Douglas Emmett
DEI
$1.98B
$284K 0.01%
7,392
+1,408
+24% +$54K
RES icon
538
RPC Inc
RES
$1.24B
$284K 0.01%
15,504
+7,208
+87% +$146K
ICLR icon
539
Icon
ICLR
$12.6B
$282K 0.01%
3,536
AVT icon
540
Avnet
AVT
$7.29B
$281K 0.01%
6,138
-16,236
-73% -$751K
CS
541
DELISTED
Credit Suisse Group
CS
$281K 0.01%
18,928
TCF
542
DELISTED
TCF Financial Corporation
TCF
$279K 0.01%
16,408
+7,056
+75% +$125K
PHG icon
543
Philips
PHG
$25.7B
$278K 0.01%
11,677
WST icon
544
West Pharmaceutical
WST
$24B
$277K 0.01%
3,388
+506
+18% +$42.3K
DCI icon
545
Donaldson
DCI
$10.9B
$276K 0.01%
6,072
+858
+16% +$37.1K
ABMD
546
DELISTED
Abiomed Inc
ABMD
$276K 0.01%
2,200
-484
-18% -$56.1K
CRI icon
547
Carter's
CRI
$1.42B
$275K 0.01%
3,060
-136
-4% -$11.7K
ROL icon
548
Rollins
ROL
$18.3B
$275K 0.01%
16,632
+6,678
+67% +$106K
BIO icon
549
Bio-Rad Laboratories Class A
BIO
$8.71B
$271K 0.01%
1,360
+204
+18% +$39.3K
AGR
550
DELISTED
Avangrid, Inc.
AGR
$268K 0.01%
6,270

Similar funds

Elkfork Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Elkfork Partners held 1,039 positions worth $3.26B, up 7.2% from $3.04B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Elkfork Partners's Q1 2017 filing shows 49 new, 487 increased, 330 reduced and 41 closed positions. Its largest new stake was L3 Technologies, Inc.: 37,180 shares worth $6.15M. The largest sale was Gilead Sciences, an estimated $27M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Elkfork Partners's largest Q1 2017 buy was L3 Technologies, Inc.: 37,180 shares worth $6.15M.
  • Elkfork Partners added most to Prologis in Q1 2017, an estimated $18.6M increase.
  • Elkfork Partners's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $27M.
  • Elkfork Partners fully exited Crown Castle in Q1 2017, selling an estimated $14.5M.
  • Elkfork Partners's ten largest holdings make up 27% of its $3.26B portfolio in Q1 2017.
  • Elkfork Partners opened 49 new positions and closed 41 in Q1 2017.
  • Elkfork Partners's portfolio value rose 7.2% quarter-over-quarter to $3.26B.

Based on Elkfork Partners's 13F filing for Q1 2017, filed 3 May 2017.